chinesezelenetz_nccn_china_edit调整格式ok.pptVIP

* * * * * * * * * Hepatitis B prophylaxis in patients undergoing chemotherapy for lymphoma: A decision analysis model. AU Saab S; Dong MH; Joseph TA; Tong MJ SO Hepatology. 2007 Aug 6;46(4):1049-1056. ? ? Hepatitis B reactivation is a major cause of morbidity and mortality in patients undergoing chemotherapy for lymphomas. These patients may experience direct liver-related complications or reduced cancer survival because of interruptions in chemotherapy. Our aim was to compare the costs and outcomes of 2 different chronic hepatitis B management strategies. In hepatitis B carriers undergoing ch